Gene Therapy Cures 'Bubble Boy Disease': Cora's Story

Imagine a common cold being a death sentence. For babies with "bubble boy disease," a rare genetic disorder leaving them without an immune system, this was a tragic reality. Now, a revolutionary gene therapy offers a permanent cure by fixing a patient's own defective stem cells. For 8-year-old Cora Oakley, who lacked a compatible donor for a traditional bone-marrow transplant, this experimental treatment was her last hope—and it successfully rebuilt her immune system from the ground up. This breakthrough represents a monumental shift from merely managing genetic disorders to eradicating them at their source. Its immediate application provides a lifeline for newborns diagnosed with severe combined immunodeficiency (SCID), offering a cure where previously there was only a high-risk treatment or a tragic prognosis.